Karsten Wassermann - Concepedia

Author

Karsten Wassermann

Novo Nordisk (Denmark)

Also Known As

K Wassermann, K. Wassermann, K. Waßermann, KARSTEN WASSERMANN, Karsten Wassermann

Publications

2.9K

Citations

H-Index

115

Concepts

All Affiliations

Novo Nordisk (Denmark)National Cancer Institute National Institutes of Health Schools of Visual Arts, The Royal Danish Academy of Fine Arts University of Copenhagen

About

Karsten Wassermann is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	27	1.6K
2	Natural Sciences	8	8	364
3	Health Sciences	7	7	544
4	Social Sciences	2	2	111
5	Engineering	1	1	15

Karsten Wassermann

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells Susan P. LeDoux, Glenn L. Wilson, E J Beecham, Carcinogenesis	1992	269
GLP‐1 derivative liraglutide in rats with <i>β</i>‐cell deficiencies: influence of metabolic state on <i>β</i>‐cell mass dynamics Jeppe Sturis, C. F. Gotfredsen, John Rømer, British Journal of Pharmacology	2003	199
Estrogen modulates estrogen receptor ? and ? expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice Shuanhu Zhou, Yoram Zilberman, Karsten Wassermann, Journal of Cellular Biochemistry ImmunologyCell DeathOsteoporotic MiceOsteoporosisMouse Bone Marrow	2001	172
Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial Inge B. Halberg, Karsten Lyby, Karsten Wassermann, The Lancet Diabetes & Endocrinology Subcutaneous Insulin GlargineDiabetes ManagementInsulin ManagementDiabetesType 2	2019	166
PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly Ji‐Ming Ye, Miguel A. Iglesias, David G. Watson, American Journal of Physiology-Endocrinology and Metabolism Fatty Liver DiseasePeroxisome Proliferator-activated ReceptorInsulin SignalingObesityMetabolic Syndrome	2003	145
Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity Per Sauerberg, Ingrid Pettersson, Lone Jeppesen, Journal of Medicinal Chemistry	2002	142
Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. Karsten Wassermann, Judit Markovits, Christine Jaxel, Molecular Pharmacology	1990	136
Differential Influences of Peroxisome Proliferator–Activated Receptorsγ and -α on Food Intake and Energy Homeostasis Philip J. Larsen, Per Bo Jensen, Rikke V. Sørensen, Diabetes	2003	111
Mobilization of small plasmids in Bacillus thuringiensis subsp. israelensis is accompanied by specific aggregation Lars Andrup, Jesper Damgaard, Karsten Wassermann Journal of Bacteriology BiologyAggregation FormationSpecific AggregationAggregation PhenotypeNatural Sciences	1993	99
Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. P M O'Connor, Karsten Wassermann, M Sarang, PubMed ImmunologyImmunoeditingCell DeathPathologyCell Cycle	1991	82

Page 1